European Archives - Page 300 of 1109 - European Medical Journal

Interview: Niamh O'Connell

When I was a medical student in the small university city of Cork, in Ireland, there was one female consultant, and she was a haematologist…

Unravelling Innovation: Advances in Genome Sequencing

In this episode, Madhuri Hegde, Senior Vice-President & Chief Scientific Officer at Revvity, Inc., discusses innovations in genomic testing and neuromuscular disorders

Hypertensive Disorders of Pregnancy and Fatal Cardiovascular Disease

Researchers link hypertensive disorders in pregnancy to doubled risk of fatal cardiovascular disease up to a year post-birth, stressing the need for ongoing care and treatment strategies.

Meet the Experts: What to do with a positive urine marker test?

Join Fred Witjes and Param Mariappan as they present new scientific evidence on urine bladder cancer biomarkers that delves into the…

Artificial Intelligence Makes Retinal Imaging 100 Times Faster

Researchers are using AI to improve the speed and image contrast of high-resolution eye imaging. This advancement offers clinicians a superior tool for evaluating age-related macular degeneration and other retinal diseases.

Personalised Model Helps Determine Lung Nodule Follow-Up

A personalised model for lung cancer screening has proven helpful for clinicians when determining how to follow up patients with pulmonary nodules identified on low-dose CT.

Interview: Damien Kenny

I was doing general paediatrics for a while, and was just not motivated by it. I found the physiology around cardiology…

The Role of Chronic Inflammation in Hidradenitis Suppurativa Progression and Patient Outcomes

This infographic spotlights hidradenitis suppurativa (HS), a chronic, inflammatory, recurrent, and debilitating skin disease of the hair…

Arrhythmia Increases Risk of Mortality in Congenital Heart Disease Patients

Adults with congenital heart disease who go on to develop arrhythmia disorders have been shown to have an increased risk of hospitalisation and mortality, according to new research. 

Roundtable: How can pharma close the gender health gap?

Robyn Widenmaier (GSK) and Tabetha Sundin (AstraZeneca) discuss whether bids to improve gender parity could be the ticket to change in women’s health.